Explorer
Vaccine approval is premature & could be dangerous: Shashi Tharoor
Shashi Tharoor tweeted, "The Covaxin has not yet had Phase 3 trials. Approval was premature and could be dangerous. Dr. Harsh Vardhan should please clarify. Its use should be avoided till full trials are over. India can start with the AstraZeneca vaccine in the meantime".
Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use.
Watch the video to know more.
Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use.
Watch the video to know more.
India
LOK SABHA DEBATE: Opposition Questions NTA Over Paper Leak Issue, Demands Major Exam Reforms
Student Protest: CGPK Founder Abhijeet Deepak Warns of Fresh Protest Over Student Issues
Punjab Politics: Congress Protests Against Punjab Government Over Alleged Paper Leak Cases
Political Protest: Samajwadi Party Targets Government Over Ram Temple Donation Allegations
Parliament Strategy: Opposition Raises Anti-Defection Law Debate Amid Parliament’s Paper Leak Discussion
View More
Top Headlines
News
Lok Sabha Passes Anti-Paper Leak Bill By Voice Vote Amid Opposition Walkout
India
'No Cash, No Paper Leaks': Punjab CM Bhagwant Mann Says 69,000 Govt Jobs Given On Merit, Blasts BJP
India
SC Clears Manmohan Singh In Talabira-II Coal Block Case Nearly 2 Years After His Death
Technology
Telegram Founder Pavel Durov Declared Wanted, Russia Files Terrorism-Linked Criminal Charges
Trending News
